Pinealon 20mg
Janoshik
Batch PINE-CA-26F-20
Pinealon
Peptide Bioregulator
Also known as Glu-Asp-Arg (EDR) tripeptide
Pinealon is a short synthetic tripeptide (Glu-Asp-Arg) of the bioregulator class, studied in research for neuroprotective signaling.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Pinealon is a short synthetic tripeptide (Glu-Asp-Arg) of the bioregulator class, studied in research for neuroprotective signaling.
Experimental models examine its influence on gene-expression regulation and antihypoxic activity under controlled laboratory conditions.
Pinealon is a short regulatory peptide investigated in research for neuroprotective and antihypoxic activity. Studies have examined proposed mechanisms of gene-expression and protein-synthesis regulation by the EDR peptide, along with antihypoxic endpoints in model systems.
The literature, while present, is comparatively limited and largely originates from short-peptide-bioregulator research programs.
Pinealon arises from research into short peptide bioregulators proposed to influence neuronal function and aging-related models.
Published work has characterized antihypoxic and neuroprotective endpoints, though the overall evidence base remains modest.
Research into Pinealon focuses on short-peptide neuroprotection and antihypoxic models. Frameworks evaluate proposed gene-expression regulation and neuroprotective endpoints; reference support is moderate relative to better-studied compounds.
3 of the 4 areas below are addressed directly by a paper cited on this page.
Short-peptide neuroprotection models
Addressed on this page by Kozina 2008, Khavinson 2020, Umnov 2013. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Kozina, LS. (2008) — [Investigation of antihypoxic properties of short peptides]
- Khavinson, V. et al. (2020) — EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease
- Umnov, RS. et al. (2013) — [Neuroprotective effects of peptides bioregulators in people of various age]
Antihypoxic-activity research
Addressed on this page by Kozina 2008. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Kozina, LS. (2008) — [Investigation of antihypoxic properties of short peptides]
Gene-expression regulation studies
Addressed on this page by Khavinson 2020. Each is linked to its source record in the references below, so what was measured — and in what system — can be read rather than taken on trust.
- Khavinson, V. et al. (2020) — EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer's Disease
Aging-model frameworks
No paper cited on this page reports on aging. This heading marks where Pinealon is discussed in the category rather than a question the cited literature answers, and it is worth knowing which of these areas has work behind it and which does not.
The references section of this page cites 3 primary papers published between 2008 and 2020 — a thin record. Every citation is linked to its PubMed or DOI record so it can be read rather than taken on trust, and the summaries above describe what those papers report rather than what the compound is claimed to do.
Research compounds attract claims that outrun their evidence. Below are the ones most often encountered for Pinealon, set against what the papers cited on this page actually report. Where the record is thin or contested, that is stated rather than smoothed over.
Pinealon is commonly described online in connection with sharper focus, better memory and improved mood. In the research literature the same compound is filed under short-peptide neuroprotection models, antihypoxic-activity research and gene-expression regulation studies.
The 3 papers cited on this page, published between 2008 and 2020 describe laboratory and animal work. None reports a controlled trial in humans. Findings in cell culture or in a rodent model describe what happened in that system; they do not establish that the same occurs in humans, and this compound is not approved for human use.
Nothing above is a statement of what this material does. It is a summary of what has been published and what has not. Eppix Labs supplies research materials only and provides no dosing, administration or protocol guidance.
Verification for Pinealon is per lot, not per product. The current 20mg lot PINE-CA-26F-20 returned 98.698% purity, 23.82 mg measured, 119.1% of the labelled 20 mg, assayed by Janoshik. Those figures are the laboratory's, published in full rather than reduced to a badge.
Purity is half the number. It states what fraction of the material in the vial is Pinealon; it says nothing about how much material is in the vial, and a short-filled vial can return a purity result that is entirely accurate. The figure that answers the second question is measured mass against expected content — for Pinealon, this lot measured 119.1% of its labelled 20 mg. Both numbers are published for every lot, whichever way they fall.
The lot code printed on the vial matches the code on the certificate for Pinealon. Matching the two is what confirms the unit in hand came from the batch that was tested — a certificate not tied to a lot code proves nothing about any particular unit.
Researchers who buy Pinealon in the United States through Eppix Labs receive the lot described by the certificate above: the code printed on the vial label is the code on the certificate, and both are searchable on the batch verification page.
- Lyophilized storage
- −20 °C long-term; stable at room temperature in transit
- After reconstitution
- 2–8 °C
- Light
- Protect from UV and direct light
- Freeze-thaw
- Avoid repeated cycles
- Vehicle
- Bacteriostatic water in most published protocols
- Format
- Lyophilized powder
Pinealon is supplied as lyophilized powder. In the dry state the material is comparatively stable, which is why it ships at ambient temperature without a cold chain; once reconstituted it is a peptide in solution and the handling constraints tighten considerably. At 3 residues it is short enough to be produced by solid-phase synthesis, and the published sequence on this page is what an identity assay is checked against.
Repeated freeze-thaw cycling is the handling error most likely to degrade material of this class, because each cycle concentrates solutes at the ice boundary. Where a protocol calls for the same vial across multiple sessions, the published literature generally describes aliquoting after reconstitution rather than re-freezing the whole volume.
Vials may appear empty on arrival. Lyophilized material collects at the base of the vial and is often not visible until the vial is inspected under direct light.
- 1 × sealed glass vial in the strength selected (20mg / Single Vial, 20mg / 5-Pack, 20mg / 10-Pack available), batch-labelled
- The batch-linked Certificate of Analysis for the exact lot shipped
- Discreet outer packaging with no product names on the exterior
- FedEx, tracked, typically 1–3 business days domestically
- Bacteriostatic water or any other reconstitution vehicle
- Syringes, needles or filters
- Dosing, administration or protocol guidance of any kind
Reconstitution materials are sourced separately. The reconstitution calculator on this site works out concentrations for a given volume, but it is an arithmetic tool for laboratory record-keeping and not a protocol.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of pinealon. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
Related
You May Also Like
Next-generation GLP receptor agonist studied for metabolic signaling and nutrient partitioning pathways
From$79.99
Dual incretin receptor agonist studied for glucose regulation, metabolic signaling, and weight pathway research
From$39.99
Studied in metabolic research for its effects on glucose regulation, appetite signaling, and energy balance.
From$59.99
Long-acting amylin analog engineered for appetite signaling, metabolic control, and energy balance research
From$99.99